RxDoctor Payments Data

Clete Kushida

Sleep Medicine · Stanford, CANPI 1780741652

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $51,970 of the $57,962 with a category attached, or 89.7%. It is spread thinly across 10 manufacturers, the largest accounting for just 21.9%. Reporting peaked in 2024 at $23,649 and has fallen 91.9% since, to $1,908 in 2025. Among sleep medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,962in general payments, 2019–2025

Across 56 payments — averaging $1035.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$13K
  • Alkermes, Inc.$12K
  • Eli Lilly$10K
  • Avadel CNS Pharmaceuticals, LLC$8K
  • Eisai Inc.$5K
  • Genentech, Inc.$4K
  • plus $6K from 4 others
$173,414in research payments, 2019–2025

Across 22 payments — averaging $7882.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eisai Inc.$116K
  • Inspire Medical Systems, Inc.$24K
  • Philips North America LLC$20K
  • Merck$13K

What the payments were for

  • Consulting fees$51,97090%
  • Travel & lodging$5,1799%
  • Food & beverage$8121%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,962 in reported general payments places this provider in the 95th percentile of 200 sleep medicine providers in California.

See all sleep medicine providers in California

Medicare billing

Part B allowed, 2024
$49,997
Medicare patients
300
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sleep medicine in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →